Trial
NCT02257619
Study of Itacitinib in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Incyte Corporation
Collaborators
—
Condition
NSCLC (Non-small Cell Lung Carcinoma)
Intervention
Itacitinib
Why stopped
Sponsor decision to not initiate part 2 due to slow enrollment and competing trials.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-21